This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Harvard South Shore Psychiatry Residency Training Program, Brockton, Massachusetts
  2. Harvard Medical School, Boston, Massachusetts
  3. Department of Psychiatry, VA Boston Healthcare System, Brockton, Massachusetts
  4. Corresponding author: Alesia A. Cloutier, DO, 940 Belmont St, Psychiatry, Brockton, MA 02301 ([email protected]).
  5. Harvard Medical School, Boston, Massachusetts
  6. Department of Neurotherapeutics, McLean Hospital, Belmont, Massachusetts
  7. Harvard South Shore Psychiatry Residency Training Program, Brockton, Massachusetts
  8. Harvard Medical School, Boston, Massachusetts
  9. Department of Psychiatry, VA Boston Healthcare System, Brockton, Massachusetts
  10. Harvard South Shore Psychiatry Residency Training Program, Brockton, Massachusetts
  11. Harvard Medical School, Boston, Massachusetts
  12. Department of Psychiatry, VA Boston Healthcare System, Brockton, Massachusetts
  13. Harvard South Shore Psychiatry Residency Training Program, Brockton, Massachusetts
  14. Harvard Medical School, Boston, Massachusetts
  15. Department of Psychiatry, VA Boston Healthcare System, Brockton, Massachusetts
  16. Harvard Medical School, Boston, Massachusetts
  17. Division of Geriatric Psychiatry, McLean Hospital, Belmont, Massachusetts
  18. Harvard Medical School, Boston, Massachusetts
  19. Division of Geriatric Psychiatry, McLean Hospital, Belmont, Massachusetts
  1. Medda P, Toni C, Perugi G. The mood-stabilizing effects of electroconvulsive therapy. J ECT. 2014;30(4):275–282. PubMed CrossRef
  2. Lewis DA, Nasrallah HA. Mania associated with electroconvulsive therapy. J Clin Psychiatry. 1986;47(7):366–367. PubMed
  3. Angst J, Angst K, Baruffol I, et al. ECT-induced and drug-induced hypomania. Convuls Ther. 1992;8(3):179–185. PubMed
  4. Kukopulos A, Reginaldi D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol. 1980;13(4):156–167. PubMed CrossRef
  5. Henry C, Sorbara F, Lacoste J, et al. Antidepressant-induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry. 2001;62(4):249–255. PubMed CrossRef
  6. Andrade C, Gangadhar BN, Swaminath G, et al. Mania as a side effect of electroconvulsive therapy. Convuls Ther. 1988;4(1):81–83. PubMed
  7. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry. 1994;151(2):169–176. PubMed CrossRef
  8. Bost-Baxter E, Reti I, Payne J. ECT in bipolar disorder: incidence of switch from depression to hypomania or mania. J Depress Anxiety. 2012;1(123):2167-1044.1000123.
  9. Elias A, Thomas N, Sackeim HA. Electroconvulsive therapy in mania: a review of 80 years of clinical experience. Am J Psychiatry. 2021;178(3):229–239. PubMed CrossRef
  10. Devanand DP, Prudic J, Sackeim HA. Electroconvulsive therapy-induced hypomania is uncommon. Convuls Ther. 1992;8(4):296–298. PubMed
  11. Weiner RD. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association. American Psychiatric Pub; 2001.
  12. Edition F. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013.
  13. Devanand DP, Sackeim HA, Decina P, et al. The development of mania and organic euphoria during ECT. J Clin Psychiatry. 1988;49(2):69–71. PubMed
  14. Moher D, Shamseer L, Clarke M, et al; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. PubMed CrossRef
  15. Delmonte D, Brioschi S, Barbini B, et al. Manic switch in bipolar patients treated with electroconvulsive therapy for treatment-resistant depression: the experience at the mood disorder unit of Milan (Italy). Eur Psychiatry. 2017;41(S1):S768–S768. CrossRef
  16. Serby M. Manic reactions to ECT. Am J Geriatr Psychiatry. 2001;9(2):180. PubMed CrossRef
  17. Andrade C, Gangadhar BN, Channabasavanna SM. Further characterization of mania as a side effect of ECT. Convuls Ther. 1990;6(4):318–319. PubMed
  18. DeQuardo JR, Tandon R. Concurrent lithium therapy prevents ECT-induced switch to mania. J Clin Psychiatry. 1988;49(4):167–168. PubMed
  19. Lee J, Arcand L, Narang P, et al. ECT-induced mania. Innov Clin Neurosci. 2014;11(11-12):27–29. PubMed
  20. Saatcioglu O, Guduk M. Electroconvulsive therapy-induced mania: a case report. J Med Case Reports. 2009;3(1):94. PubMed CrossRef
  21. Li DJ, Li HJ, Lin CH. Electroconvulsive therapy-induced manic episode for a patient with bipolar depression: a case report. J ECT. 2015;31(2):e30–e31. PubMed CrossRef
  22. Thomas RK, White PJ, Dursun S. Treating electroconvulsive therapy-induced mania with more electroconvulsive therapy: evidence for electroconvulsive therapy as the ultra-mood stabilizer. SAGE Open Med Case Rep. 2018;6:X18799236. PubMed CrossRef
  23. Sanders RD, Deshpande AS. Mania complicating ECT. Br J Psychiatry. 1990;157(1):153–154. PubMed CrossRef
  24. Zavorotnyy M, Diemer J, Patzelt J, et al. Occurrence of ultra-rapid cycling during electroconvulsive therapy in bipolar depression. World J Biol Psychiatry. 2009;10(4 Pt 3):987–990. PubMed CrossRef
  25. Huber JP, Burke D. ECT and lithium in old age depression—cause or treatment of rapid cycling? Australas Psychiatry. 2015;23(5):500–502. PubMed CrossRef
  26. Mohammad O, Osser DN. The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania. Harv Rev Psychiatry. 2014;22(5):274–294. PubMed CrossRef
  27. Payne NA, Prudic J. Electroconvulsive therapy: Part I, a perspective on the evolution and current practice of ECT. J Psychiatr Pract. 2009;15(5):346–368. PubMed CrossRef
  28. Naguib M, Koorn R. Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management. CNS Drugs. 2002;16(4):229–247. PubMed CrossRef
  29. Martin BA, Kramer PM. Clinical significance of the interaction between lithium and a neuromuscular blocker. Am J Psychiatry. 1982;139(10):1326–1328. PubMed CrossRef
  30. Lippmann SB, Tao CA. Electroconvulsive therapy and lithium: safe and effective treatment. Convuls Ther. 1993;9(1):54–57. PubMed
  31. Patel RS, Bachu A, Youssef NA. Combination of lithium and electroconvulsive therapy (ECT) is associated with higher odds of delirium and cognitive problems in a large national sample across the United States. Brain Stimul. 2020;13(1):15–19. PubMed CrossRef
  32. Weiner RD, ed. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging (A Task Force Report of the American Psychiatric Association). 2nd ed. Psychiatric Association; 2001.
  33. Rakesh G, Thirthalli J, Kumar CN, et al. Concomitant anticonvulsants with bitemporal electroconvulsive therapy: a randomized controlled trial with clinical and neurobiological application. J ECT. 2017;33(1):16–21. PubMed CrossRef
  34. Jahangard L, Haghighi M, Bigdelou G, et al. Comparing efficacy of ECT with and without concurrent sodium valproate therapy in manic patients. J ECT. 2012;28(2):118–123. PubMed CrossRef
  35. Penland HR, Ostroff RB. Combined use of lamotrigine and electroconvulsive therapy in bipolar depression: a case series. J ECT. 2006;22(2):142–147. PubMed CrossRef
  36. Turek IS. Combined use of ECT and psychotropic drugs: antidepressives and antipsychotics. Compr Psychiatry. 1973;14(6):495-502.
  37. Friedel RO. The combined use of neuroleptics and ECT in drug resistant schizophrenic patients. Psychopharmacol Bull. 1986;22(3):928–930. PubMed
  38. Aoba A, Kakita Y, Yamaguchi N, et al. Electric convulsive therapy (ECT) increases plasma and red blood cell haloperidol neuroleptic activities. Life Sci. 1983;33(18):1797–1803. PubMed CrossRef
  39. Sikdar S, Kulhara P, Avasthi A, et al. Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry. 1994;164(6):806–810. PubMed CrossRef
  40. Nascimento AL, Appolinario JC, Segenreich D, et al. Maintenance electroconvulsive therapy for recurrent refractory mania. Bipolar Disord. 2006;8(3):301–303. PubMed CrossRef
  41. Poyurovsky M, Weizman A. Safety and effectiveness of combined ECT and clozapine in treatment-resistant mania. Eur Psychiatry. 1996;11(6):319–321. PubMed CrossRef
  42. Chanpattana W. Combined ECT and clozapine in treatment-resistant mania. J ECT. 2000;16(2):204–207. PubMed CrossRef
  43. Mohan TS, Tharyan P, Alexander J, et al. Effects of stimulus intensity on the efficacy and safety of twice-weekly, bilateral electroconvulsive therapy (ECT) combined with antipsychotics in acute mania: a randomised controlled trial. Bipolar Disord. 2009;11(2):126–134. PubMed CrossRef
  44. Haskett RF, Loo C. Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia. J ECT. 2010;26(3):196–201. PubMed CrossRef
  45. Abbott CC, Miller J, Lloyd M, et al. Electroconvulsive therapy electrode placement for bipolar state-related targeted engagement. Int J Bipolar Disord. 2019;7(1):11. PubMed CrossRef